What is the recommended dosing schedule for paroxetine (Paxil) in adults, elderly patients, those with hepatic impairment, and children with obsessive‑compulsive disorder?

Paxil (Paroxetine) Dosing

Start paroxetine at 10 mg daily in adults for depression and anxiety disorders, with a maximum of 40-60 mg/day depending on indication; elderly patients and those with hepatic impairment should start at 10 mg daily with a maximum of 40 mg/day; children with OCD should start at 10 mg daily with a maximum of 50 mg/day. 1

Adult Dosing by Indication

Major Depressive Disorder

• Starting dose: 10 mg daily (morning or evening) 2
• Titration: Increase by 10 mg increments at weekly intervals as tolerated 3
• Effective dose: 20 mg/day for most patients 3
• Maximum dose: 40-60 mg/day 2, 4

The 20 mg dose is both the minimal effective dose and optimal dose for most patients. Only increase if inadequate response after 1-3 weeks 3.

Obsessive-Compulsive Disorder (OCD)

• Starting dose: 10 mg daily 4
• Titration: Increase by 10 mg increments at weekly intervals 4
• Effective dose: 20-40 mg/day 5
• Maximum dose: 60 mg/day 4

Important: OCD requires higher doses and longer treatment duration than depression. Improvements typically plateau at 12 weeks, and successful treatment should continue for at least 12 months 6.

Panic Disorder, Social Anxiety Disorder, Generalized Anxiety Disorder

• Starting dose: 10 mg daily 4
• Effective dose: 20 mg/day 4
• Maximum dose: 60 mg/day 4

Special Populations

Elderly Patients (≥60 years)

• Starting dose: 10 mg daily 2, 1
• Therapeutic range: 20-40 mg/day 2, 3
• Maximum dose: 40 mg/day 2, 1

Lower doses are necessary due to altered pharmacokinetics in elderly patients.

Hepatic Impairment

• Starting dose: 10 mg daily 1
• Maximum dose: 40 mg/day 1

Critical consideration: Patients with cirrhosis show significantly higher plasma levels (dose-corrected AUC 89 vs 43 h·ng/mL per mg) and prolonged elimination half-life (83 vs 36 hours) compared to healthy controls 7. Keep doses in the lower therapeutic range.

Renal Impairment (Severe)

• Starting dose: 10 mg daily 1
• Maximum dose: 40 mg/day 1

Children and Adolescents with OCD

• Age range: 7-17 years 5
• Starting dose: 10 mg daily 5, 8
• Titration: Increase gradually based on response and tolerability
• Dose range: 10-50 mg/day 5
• Maximum dose: 60 mg/day 8

Pediatric safety note: Paroxetine has been associated with increased risk of suicidal thinking or behavior compared to other SSRIs 9. Close monitoring is essential, especially in the first weeks of treatment and after dose changes.

Administration Guidelines

Timing and Food

• Give as single daily dose, typically in the morning 2, 1
• Can be taken with or without food 1
• For controlled-release formulation (Paxil CR): swallow whole, do not chew or crush 1

Titration Schedule

• Increase dose at weekly intervals minimum 4, 9, 3
• Use 10 mg increments for immediate-release formulation 3
• For anxiety disorders, slower titration (1-2 week intervals) may reduce initial activation/agitation 9

Duration of Treatment

• Acute treatment: Continue for at least 4-8 weeks at therapeutic dose to assess full response 2
• Maintenance: Several months to 1 year for depression; at least 12 months for OCD 1, 6
• Anxiety disorders: Often require long-term treatment given chronic nature 1

Critical Safety Considerations

Discontinuation Syndrome

Paroxetine has the highest risk of discontinuation syndrome among SSRIs 9. Symptoms include dizziness, fatigue, nausea, headaches, paresthesias, anxiety, and irritability.

Discontinuation protocol:

• Taper gradually over 10-14 days minimum 2
• If intolerable symptoms occur, resume previous dose and taper more slowly 1
• Never stop abruptly

Drug Interactions

• Contraindicated: MAOIs (allow 14 days washout period) 4, 9, 1
• Significant interactions: Drugs metabolized by CYP2D6 (paroxetine is a potent inhibitor) 9
• Caution: Combining with other serotonergic drugs increases risk of serotonin syndrome 9

Monitoring Requirements

• Baseline: Blood pressure, pulse, weight (in context of physical examination) 10
• Ongoing: Monitor for suicidal ideation, especially first few months and after dose changes 4
• Hepatic function: Consider monitoring if symptoms of liver dysfunction develop 11, 12

Common Adverse Effects

Most common (≥5% and twice placebo rate): abnormal ejaculation, nausea, somnolence, sweating, tremor, dizziness, insomnia, constipation, decreased libido, female genital disorders (anorgasmia) 1

Specific Warnings

• Less activating but more anticholinergic than other SSRIs 2
• Increased suicidality risk compared to other SSRIs in pediatric populations 9
• Hepatotoxicity: Rare but can be severe; discontinue if signs of liver dysfunction 11, 12
• Pregnancy: Consider tapering in third trimester due to neonatal complications 1

Practical Algorithm for Dose Selection

1. Determine indication and patient population
2. Start at 10 mg daily (all indications, all populations)
3. Assess response at 1-3 weeks:
   • If adequate response → maintain dose
   • If inadequate response → increase by 10 mg
4. Continue weekly increases until:
   • Therapeutic benefit achieved, OR
   • Dose-limiting side effects, OR
   • Maximum dose reached (40-60 mg depending on population)
5. Optimize at 6-12 weeks, then maintain for appropriate duration
6. When discontinuing: Taper over minimum 2 weeks, slower if needed